Meda takes over two additional OTC products from GSK
Earlier in 14 December 2010, Meda took over three OTC consumer products from GSK. Meda is an international specialty pharma company engaged in marketing and product development in
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.